4.5 Article

Novel 5-substituted 1H-tetrazoles as cyclooxygenase-2 (COX-2) inhibitors

Journal

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
Volume 22, Issue 6, Pages 2235-2238

Publisher

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.bmcl.2012.01.093

Keywords

Cyclooxygenase; COX-2 inhibitors; 5-Substituted 1H-tetrazoles

Funding

  1. Dianne and Irving Kipnes Foundation
  2. Canadian Institute for Health Research (CIHR)

Ask authors/readers for more resources

A series of novel 5-substituted 1H-tetrazoles as cyclooxygenase-2 (COX-2) inhibitors was prepared via treatment of various diaryl amides with tetrachlorosilane/sodium azide. All compounds were tested in cyclooxygenase (COX) assays in vitro to determine COX-1 and COX-2 inhibitory potency and selectivity. Tetrazoles contained a methylsulfonyl or sulfonamide group as COX-2 pharmacophore displayed only low inhibitory potency towards COX-2. Most potent compounds showed IC50 values of 6 and 7 mu M for COX-2. All compounds showed IC50 values greater 100 mu M for COX-1 inhibition. (C) 2012 Elsevier Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Chemistry, Organic

Diaryl-Substituted (Dihydro)pyrrolo[3,2,1-hi]indoles, a Class of Potent COX-2 Inhibitors with Tricyclic Core Structure

Markus Laube, Cemena Gassner, Sai Kiran Sharma, Robert Guenther, Arne Pigorsch, Jonas Koenig, Martin Koeckerling, Frank Wuest, Jens Pietzsch, Torsten Kniese

JOURNAL OF ORGANIC CHEMISTRY (2015)

Article Chemistry, Physical

Synthesis and crystal structure of N-[(dimethylamino)methylidene]-4-[1-(4-nitropheny1)-1H-tetrazol-5-yl]-benzenesulfonamide: Molecular docking and bioassay studies as cyclooxygenase-2 inhibitor

Baker Jawabrah Al-Hourani, Musa I. El-Barghouthi, Robert McDonald, Wajdy Al-Awaida, Sai Kiran Sharma, Frank Wuest

JOURNAL OF MOLECULAR STRUCTURE (2016)

Article Radiology, Nuclear Medicine & Medical Imaging

Preclinical 89Zr Immuno-PET of High-Grade Serous Ovarian Cancer and Lymph Node Metastasis

Sai Kiran Sharma, Kuntal K. Sevak, Sebastien Monette, Sean D. Carlin, James C. Knight, Frank R. Wuest, Evis Sale, Brian M. Zeglis, Jason S. Lewis

JOURNAL OF NUCLEAR MEDICINE (2016)

Article Radiology, Nuclear Medicine & Medical Imaging

Molecular Imaging of Ovarian Cancer

Sai Kiran Sharma, Brandon Nemieboka, Evis Sala, Jason S. Lewis, Brian M. Zeglis

JOURNAL OF NUCLEAR MEDICINE (2016)

Review Radiology, Nuclear Medicine & Medical Imaging

Site-Specifically Labeled Immunoconjugates for Molecular Imaging-Part 2: Peptide Tags and Unnatural Amino Acids

Pierre Adumeau, Sai Kiran Sharma, Colleen Brent, Brian M. Zeglis

MOLECULAR IMAGING AND BIOLOGY (2016)

Review Radiology, Nuclear Medicine & Medical Imaging

Site-Specifically Labeled Immunoconjugates for Molecular Imaging-Part 1: Cysteine Residues and Glycans

Pierre Adumeau, Sai Kiran Sharma, Colleen Brent, Brian M. Zeglis

MOLECULAR IMAGING AND BIOLOGY (2016)

Review Biochemical Research Methods

Preclinical optimization of antibody-based radiopharmaceuticals for cancer imaging and radionuclide therapyModel, vector, and radionuclide selection

Lukas M. Carter, Sophie Poty, Sai Kiran Sharma, Jason S. Lewis

JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS (2018)

Article Biochemical Research Methods

Understanding the in vivo fate of radioimmunoconjugates for nuclear imaging

Delphine Vivier, Sai Kiran Sharma, Brian M. Zeglis

JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS (2018)

Article Chemistry, Medicinal

Synthesis, bioassay studies, and molecular docking of novel 5-substituted 1H tetrazoles as cyclooxygenase-2 (COX-2) inhibitors

Baker Jawabrah Al-Hourani, Sai Kiran Sharma, Jatinder Kaur, Frank Wuest

MEDICINAL CHEMISTRY RESEARCH (2015)

Article Chemistry, Organic

Synthesis of three 18F-labelled cyclooxygenase-2 (COX-2) inhibitors based on a pyrimidine scaffold

Ole Tietz, Sai Kiran Sharma, Jatinder Kaur, Jenilee Way, Alison Marshall, Melinda Wuest, Frank Wuest

ORGANIC & BIOMOLECULAR CHEMISTRY (2013)

Article Biochemical Research Methods

Improved soluble expression of a single-chain antibody fragment in E. coli for targeting CA125 in epithelial ovarian cancer

Sai Kiran Sharma, Mavanur R. Suresh, Frank R. Wuest

PROTEIN EXPRESSION AND PURIFICATION (2014)

Article Chemistry, Multidisciplinary

2,3-Diaryl-substituted indole based COX-2 inhibitors as leads for imaging tracer development

Markus Laube, Christoph Tondera, Sai Kiran Sharma, Nicole Bechmann, Franz-Jacob Pietzsch, Arne Pigorsch, Martin Koeckerling, Frank Wuest, Jens Pietzsch, Torsten Kniess

RSC ADVANCES (2014)

Article Radiology, Nuclear Medicine & Medical Imaging

Immuno-PET of epithelial ovarian cancer: harnessing the potential of CA125 for non-invasive imaging

Sai Kiran Sharma, Melinda Wuest, Monica Wang, Darryl Glubrecht, Bonnie Andrais, Suzanne E. Lapi, Frank Wuest

EJNMMI RESEARCH (2014)

Article Radiology, Nuclear Medicine & Medical Imaging

Influence of Fc Modifications and IgG Subclass on Biodistribution of Humanized Antibodies Targeting L1CAM

Sai Kiran Sharma, Maya Suzuki, Hong Xu, Joshua A. Korsen, Zachary Samuels, Hongfen Guo, Brandon Nemieboka, Alessandra Piersigilli, Kimberly J. Edwards, Nai-Kong Cheung, Jason S. Lewis

Summary: Immuno-PET is a powerful tool for studying the biodistribution of antibodies in vivo. This study used radiolabeled HuE71 IgG1 and IgG4 antibodies with the same variable heavy- and light-chain sequences but different Fc portions to investigate their in vivo biodistribution in SKOV3 ovarian cancer xenografted nude mice. The results highlight the influence of Fc modifications and the choice of IgG subclass on the biodistribution of antibodies.

JOURNAL OF NUCLEAR MEDICINE (2022)

Article Oncology

Targeting lysyl oxidase for molecular imaging in breast cancer

Melinda Wuest, Manuela Kuchar, Sai Kiran Sharma, Susan Richter, Ingrit Hamann, Monica Wang, Larissa Vos, John R. Mackey, Frank Wuest, Reik Loeser

BREAST CANCER RESEARCH (2015)

Article Chemistry, Medicinal

Design and synthesis of a library of C2-substituted sulfamidoadenosines to probe bacterial permeability

Shibin Zhao, Julian Maceren, Mia Chung, Samantha Stone, Raphael Geiben, Melissa L. Boby, Bradley S. Sherborne, Derek S. Tan

Summary: Antibiotic resistance is a major threat to public health, with Gram-negative bacteria presenting unique challenges due to their low permeability and efflux pumps. Limited understanding of the chemical rules for overcoming these barriers hinders antibacterial drug discovery. Efforts to address this issue, such as screening compound libraries and using cheminformatic analysis, have led to the design of sulfamidoadenosines with diverse substituents, showing potential utility in accumulation in Escherichia coli.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2024)

Article Chemistry, Medicinal

Design of MERS-CoV entry inhibitory short peptides based on helix-stabilizing strategies

Jichun Li, Qing Li, Shuai Xia, Jiahuang Tu, Longbo Zheng, Qian Wang, Shibo Jiang, Chao Wang

Summary: This study successfully developed a short peptide mimetic as a MERS-CoV fusion inhibitor by reproducing the key recognition features of the HR2 helix. The resulting 23-mer lipopeptide showed comparable inhibitory effect to the 36-mer HR2 peptide HR2P-M2. This has important implications for developing short peptide-based antiviral agents to treat MERS-CoV infection.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2024)

Article Chemistry, Medicinal

Development of novel β2-adrenergic receptor agonists for the stimulation of glucose uptake - The importance of chirality and ring size of cyclic amines

Krista Jaunsleine, Linda Supe, Jana Spura, Sten van Beek, Anna Sandstrom, Jessica Olsen, Carina Halleskog, Tore Bengtsson, Ilga Mutule, Benjamin Pelcman

Summary: Beta(2)-adrenergic receptor agonists can stimulate glucose uptake by skeletal muscle cells and are therefore potential treatments for type 2 diabetes. The chirality of compounds has a significant impact on the activity of these agonists. This study found that certain synthesized compounds showed higher glucose uptake activity. These findings provide important information for the design of novel beta(2)AR agonists for T2D treatment.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2024)

Article Chemistry, Medicinal

Conformationally constrained potent inhibitors for enhancer of zeste homolog 2 (EZH2)

Xin Xu, Jia Chen, Guan Wang, Xiaojuan Zhang, Qiang Li, Xiaobo Zhou, Fengying Guo, Min Li

Summary: The study focuses on EZH2, a promising therapeutic target for various types of cancers. Researchers designed and synthesized a series of novel derivatives aiming to enhance the EZH2 inhibition activity. Among them, compound 28 displayed potent EZH2 inhibition activity and showed high anti-proliferative effects in lymphoma cell lines and xenograft mouse models. The study suggests that compound 28 has potential as a therapeutic candidate for EZH2-associated cancers.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2024)

Article Chemistry, Medicinal

The potential of Rhein's aromatic amines for Parkinson's disease prevention and treatment: α-Synuclein aggregation inhibition and disaggregation of preformed fibers

Wei Zhang, Wei Liu, Ya-Dong Zhao, Li-Zi Xing, Ji Xu, Rui-Jun Li, Yun-Xiao Zhang

Summary: This study developed a series of aromatic amide derivatives based on Rhein and investigated their inhibitory activity against alpha-Syn aggregation. Two of these compounds showed promising potential in treating Parkinson's disease by stabilizing alpha-Syn's conformation and disassembling alpha-Syn oligomers and fibrils.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2024)

Article Chemistry, Medicinal

Design, synthesis and biological evaluation of novel cationic liposomes loaded with melphalan for the treatment of cancer

Mani Sharma, S. S. S. S. Sudha Ambadipudi, Neeraj Kumar Chouhan, V. Lakshma Nayak, Srihari Pabbaraja, Sai Balaji Andugulapati, Ramakrishna Sistla

Summary: Therapeutically active lipids in drug delivery systems can enhance the safety and efficacy of treatment. The liposome formulation created using synthesized biologically active lipids showed additive anti-cancer effects and reduced tumorigenic potential.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2024)